K2 Principal Fund’s DermTech, Inc. Common Stock DMTK Stock Holding History

K2 Principal Fund’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-319,452	Closed	-$6.52M	–	342
2018 Q4	$6.52M	Buy	319,452 +500	+0.2%	+$10.2K	0.99%	20
2018 Q3	$6.46M	Hold	318,952	–	–	0.62%	49
2018 Q2	$6.35M	Hold	318,952	–	–	0.49%	58
2018 Q1	$6.3M	Sell	318,952 -49,198	-13%	-$964K	0.36%	69
2017 Q4	$7.16M	Buy	368,150 +35,650	+11%	+$695K	0.52%	50
2017 Q3	$6.46M	Buy	+332,500	New	+$6.47M	0.43%	63

Other funds holding DMTK

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

K2 Principal Fund's DMTK Position: Q1 2019 in Review

K2 Principal Fund sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2019, closing a stake of 319,452 shares — an estimated $6.52M sold.

K2 Principal Fund first reported a position in DMTK in Q3 2017 and held it in 6 quarters. The position peaked at $7.16M in Q4 2017. 5 funds tracked by Wall St. Rank hold DMTK as of Q1 2019.

K2 Principal Fund reported no remaining DermTech, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
K2 Principal Fund sold 319,452 DermTech, Inc. Common Stock shares in Q1 2019, an estimated $6.52M.
K2 Principal Fund first reported a position in DermTech, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
K2 Principal Fund's DermTech, Inc. Common Stock position peaked at $7.16M in Q4 2017.
5 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2019.

Based on K2 Principal Fund's 13F filing for Q1 2019, filed 14 May 2019.